BTIG sees bright outlook for Globus Medical, J&J in spinal implant market

NuVasive

31/08/2021 13:47

** Brokerage BTIG says it is most positive on long-term
growth prospects for Globus Medical  GMED.N  and Johnson &
Johnson  JNJ.N  in the spinal implants market
    ** Says its survey of U.S. surgeons indicates that GMED and
JNJ would see the most market share gains in the coming years
while Medtronic  MDT.N  is poised to lose share
    ** Over the past three years, market share gains have been
most evident for GMED, MDT and Zimmer Biomet  ZBH.N  while
NuVasive  NUVA.O  and Stryker  SYK.N  have experienced weakness,
says brokerage
    ** Backlog due to COVID-19-induced rescheduling of
procedures showing decline, but may persist for some time and
reimbursement dynamics appear unchanged- brokerage
    ** However, BTIG says expectations for normalization of
procedures have been pushed back to Q2 2022 as infections from
the Delta variant rise
    ** NUVA, SYK, JNJ, MDT, GMED up between 5% and 27% so far
this year, while ZBH had fallen 2.8% up to the last close

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))